|Articles|November 1, 2019
- Applied Clinical Trials-11-01-2019
- Volume 28
- Issue 11
Applied Clinical Trials, November 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
2020: The Industry’s Future Awaitsalmost 7 years ago
Establishing Early Phase Capabilities in Malaysiaalmost 7 years ago
How ICH E6 (R2) Offers Wins with Risk-Based Study Executionalmost 7 years ago
News Notesalmost 7 years ago
The Challenges in Fulfilling the Promise of Precision Oncologyalmost 7 years ago
Sponsors Struggle with Trial Disclosure, Patient Privacy Requirementsalmost 7 years ago
The ‘Quest’ For an Effective Partner in Pharma And Biotechalmost 7 years ago
China: A New Era of Drug Development and Innovationalmost 7 years ago
Who’s Going to Be Disrupted by Shifts in European Health Strategy?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
2
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
3
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5